Eastern Analytical Symposium & Exposition 2024 Final Program

Eastern Analytical Symposium & Exposition 2024 — Final Program Summary

Significance of the topic
The Eastern Analytical Symposium & Exposition (EAS) is a major regional meeting that integrates advances across the analytical chemistry spectrum. The 2024 program emphasized cross-disciplinary problem solving — combining chromatography, mass spectrometry, spectroscopy, NMR, separations science, and data science — to address pressing applied challenges such as PFAS analysis, nitrosamine control, biopharmaceutical characterization, oligonucleotide analytics, environmental monitoring, and forensic field analysis. The meeting supports workforce development, regulatory alignment (ICH/USP), and technology transfer between academia, industry, and government, making it highly relevant for laboratories involved in QA/QC, R&D, regulatory submissions, and forensic casework.

Objectives and overview of the event

• Present an overview of scientific and technological developments across analytical disciplines via technical sessions, short courses, workshops, and an exposition.
• Facilitate knowledge transfer on regulatory topics (e.g., ICH Q14, USP expectations), method validation, and lifecycle management.
• Showcase advances in automation, high-throughput experimentation, and AI/ML applied to analytical method development and data analysis.
• Foster networking, mentoring, and student engagement through awards, poster sessions, employment services, and professional-development workshops.

Methodology and program structure

• Format: multi-day program with full-day short courses, parallel technical sessions, e-poster sessions, exhibitor demonstrations, and social/networking events.
• Knowledge transfer channels: invited lectures (including a keynote by the USP CEO), award lectures, vendor demos, short courses covering hands-on and conceptual topics, and themed “conferences-in-miniature” (e.g., PFAS, oligonucleotides, spectroscopy, chromatography, mass spectrometry, data science).
• Audience: practicing analytical scientists from industry, academia, regulatory agencies, and students (undergraduate/graduate).

Used instrumentation (summary of instrument types and platforms highlighted)

• Chromatography platforms: HPLC/UHPLC, SFC, GC, GC×GC, capillary LC, HPTLC, monodisperse fully porous particle (MFPP) columns, inert-column hardware and modern column chemistries.
• Mass spectrometry: high-resolution QToF, LC–MS/MS, GC–MS/MS, acoustic ejection MS, ambient/automated ambient MS, droplet-APCI-MS, FIA-MS, charge-detection MS for megadalton particles, MALDI imaging, ion mobility and high-throughput platforms.
• Spectroscopy and imaging: Raman (including handheld and deep UV resonance), FTIR, O-PTIR/submicron IR, near-infrared, hyperspectral imaging, tip-enhanced Raman (TERS), second harmonic generation, photothermal IR, and vibrational circular dichroism.
• Nuclear magnetic resonance: quantitative 1H and 19F qNMR approaches, specialized MAS and switched-angle spinning probes, 2D and isotope-shift strategies for structure elucidation, and automated qNMR data-analysis prototypes.
• Atomic and elemental methods: ICP-MS including single-particle sp-ICP-MS, LIBS, combustion ion chromatography for halogen analysis, plasma-based elemental detection (including ambient-air plasmas), and VUV/GC-VUV detection.
• Structural/biophysical tools: cryo-EM, SPR, light scattering and MALS, submicron microscopy, and automated sample-prep/affinity SPE systems for biologics.
• Field and portable tools: handheld Raman and other portable spectrometers, FDA satellite laboratory kits, and workflows for in-field forensic sampling.
• Software and data tools: chromatography modeling (DryLab, predictive retention models), method lifecycle/QbD platforms (Fusion QbD–style), Empower and QbD integration, machine learning for retention/time prediction and spectral classification, and automated data pipelines for method verification and quality assurance.

Main themes, highlights and discussion of presented advances

• Regulatory and method lifecycle alignment: Sessions focused on ICH Q14, USP expectations, and analytical lifecycle management emphasized structured method development, enhanced validation strategies, and links between Analytical Target Profiles and Quality Target Product Profiles.
• PFAS and environmental analytics: multiple talks described targeted and non-targeted PFAS workflows (LC-MS/MS, SERS, combustion ion chromatography), improved sample extraction for complex matrices, and analytical strategies to quantify “missing fluorine” in legacy materials.
• Nitrosamines and impurity control: presentations covered formation mechanisms (NOx/nitrite pathways), control strategies in manufacturing, and LC–MS method development challenges for trace NDSRIs.
• Oligonucleotide and modality analytics: sessions addressed hybridization LC–MS assays, oligo separation strategies (ion-pair-free approaches, dedicated columns), and analytical control strategies specific to siRNA/mRNA/ASO products.
• Biopharma characterization and bioanalysis: multi-dimensional separation workflows, submicron IR and O-PTIR imaging for particulate/aggregate analysis, charge-detection MS for large complexes, and improved assays for excipient and process-related degradants.
• High-throughput and automation: acoustic ejection MS, automated ambient MS platforms, standardized automated LC method development workflows, and high-throughput thermodynamic/solubility screening approaches showcased acceleration of discovery and formulation workflows.
• AI/ML and data science: retention prediction models, machine learning for spectral classification (conformal prediction, deep learning for imaging and coatings), and chemometric algorithms for blind source separation and feature extraction in hyphenated datasets.
• Sustainable laboratory practices: sessions covered greener chromatographic strategies, sustainable sample-prep and PAT in continuous manufacturing, and adoption of SFC and other lower-impact separation modes.
• Forensics and portable analysis: fusion of microscopy, Raman, GC×GC, and mass-spectrometry approaches for field-deployable evidence analysis; emphasis on method robustness and detection limits in situ.
• Awards and thought leadership: award lectures highlighted advances in vibrational spectroscopy, mass spectrometry, separation science, magnetic resonance, and analytical chemistry applications to materials and biomedical problems. Keynote addressed quality-capacity building for low- and middle-income countries.

Practical benefits and applications for analytical laboratories

• Improved method robustness and regulatory readiness via QbD-driven workflows, retention prediction, and lifecycle-oriented validation approaches.
• Faster R&D cycles and screening throughput enabled by automated and acoustic-ejection MS platforms and integrated high-throughput LC–MS workflows.
• Enhanced capability for complex modalities (oligonucleotides, biologics, vaccines) using multi-dimensional separations, specialized columns, and orthogonal biophysical characterization (cryo-EM, light scattering, O-PTIR).
• Better environmental and forensic surveillance through field-capable spectrometers, advanced imaging, and non-targeted halogen/fluorine quantitation methods.
• Laboratory sustainability gains by adopting greener separation modes (SFC), solvent-minimizing strategies, and process analytical technology for continuous manufacturing.
• Workforce development: short courses, student awards, mentoring, and employment services help build practical skills in NMR, chromatography, spectroscopy, data science, and regulatory expectations.

Future trends and opportunities for application

• Deeper AI/ML integration across the analytical lifecycle: ML-driven retention prediction, spectral classification with uncertainty quantification, and autonomous experiment optimization will become standard in method development and troubleshooting.
• Automation and miniaturization: further adoption of high-throughput, acoustic and ambient MS, coupled with automated sample prep and robotics, will compress timelines for screening and QC release testing.
• Increased emphasis on method transferability and in silico method verification: simulation tools and digital method dossiers will reduce wet-lab burden and improve reproducibility.
• Advanced sub-micron and multimodal imaging: O-PTIR, combined Raman/IR modalities, and correlative cryo-EM–mass spectrometry will enhance spatially resolved chemical characterization of complex samples (biologics, materials, microplastics).
• Green analytics and lifecycle sustainability: expansion of solvent- and energy-efficient chromatographic methods (SFC, fast UHPLC with greener solvents) and process analytical technologies for continuous production.
• Capacity building and global quality initiatives: workshops and consultation services (as advocated by USP leadership) will expand analytical capability in low- and middle-income regions, supporting vaccine and pharmaceutical quality worldwide.
• Standard-free and element-specific quantitation approaches: plasma-based, halogen/element detection strategies will improve absolute quantitation for metabolites and impurities where reference standards are scarce.

Conclusion
The 2024 EAS Final Program presented a broad, application-driven view of contemporary analytical science. Cross-cutting themes — integration of orthogonal techniques, regulatory-aligned method lifecycle management, automation/high-throughput experimentation, and AI-driven data science — dominated sessions and vendor exhibits. The program reinforced the role of analytical scientists as partners in problem solving across pharmaceuticals, environmental monitoring, forensics, and materials science, while highlighting practical tools and workflows for immediate adoption in laboratory practice.

References
No formal literature references were provided in the program document; the summary synthesizes content from the EAS 2024 Final Program and session abstracts as published by the conference organizers.